KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.252 30 days ( 41.67 % )
Last Price $1.19 0 %
High/ Low $1.17 - $1.20 6.84%
Chg 7 Days -1.65 % $1.21 $1.19
Chg 30 Days -36.87 % $1.89 $1.19
Chg 12 mos -68.68 % $3.80 $1.19
Trend - 3 mos -54.84 % Width: 63.01 %
Trend - 12 mos -38.31 % Width: 263.84 %
Pred. range - 3 mos $0.376 - $0.614 -68.36 % - -48.43 %
Pred. range - 12 mos $0.622 - $2.26 -47.70 % - 90.29 %
Short MA avg 3 mos Buy Apr 17, 2024 - 7 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Jan 17, 2024 - 70 days
Long MA avg 12 mos Sell Sep 29, 2023 - 144 days
Short/Long MA avg 12 mos Sell Oct 19, 2023 - 130 days
Pivot Short Buy Apr 11, 2024 - 11 days
Bollinger Buy Mar 18, 2024 - 28 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Akari Therapeutics Plc

Akari Therapeutics Plc Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ... AKTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT